ALLK - Allakos Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Redwood City,
United States
Type: Equity
ALLK price evolution
ALLK
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $66.44 | $70.52 | $67.38 | $93.85 |
| Short term investments | $104.35 | $123.39 | $153.72 | $158.75 |
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $179.89 | $218.28 | $251.56 | $282.86 |
| Long term investments | ||||
| Property, plant & equipment | $57.51 | $59.13 | $60.94 | $62.57 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $63.72 | $65.22 | $67.63 | $67.55 |
| Total investments | $104.35 | $123.39 | $153.72 | $158.75 |
| Total assets | $243.61 | $283.5 | $319.2 | $350.41 |
| Current liabilities | ||||
| Accounts payable | $1.76 | $0.92 | $4.31 | $9.1 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $36.58 | $23.45 | $24.48 | $29.53 |
| Long term debt | $38.22 | $39 | $39.73 | $40.43 |
| Total noncurrent liabilities | $38.22 | $39 | $39.73 | $40.43 |
| Total debt | $38.22 | $39 | $39.73 | $40.43 |
| Total liabilities | $74.79 | $62.45 | $64.22 | $69.96 |
| Shareholders' equity | ||||
| Retained earnings | -$1118.48 | -$1055.93 | -$1010.3 | -$975.18 |
| Other shareholder equity | $0.05 | -$0.07 | -$0.16 | $0.01 |
| Total shareholder equity | $168.82 | $221.04 | $254.98 | $280.45 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $66.44 | $87.22 | $152.82 | $207.18 |
| Short term investments | $104.35 | $192.57 | $271.42 | $451.82 |
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $179.89 | $308.84 | $451.58 | $669.27 |
| Long term investments | ||||
| Property, plant & equipment | $57.51 | $69.37 | $74.81 | $48.08 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $63.72 | $77.58 | $83.24 | $50.35 |
| Total investments | $104.35 | $192.57 | $271.42 | $451.82 |
| Total assets | $243.61 | $386.42 | $534.82 | $719.62 |
| Current liabilities | ||||
| Accounts payable | $1.76 | $4.83 | $13.69 | $13.96 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $36.58 | $30.04 | $40.25 | $22.45 |
| Long term debt | $38.22 | $45.95 | $49.1 | $42.77 |
| Total noncurrent liabilities | $38.22 | $45.95 | $49.1 | $42.77 |
| Total debt | $38.22 | $45.95 | $49.1 | $42.77 |
| Total liabilities | $74.79 | $75.99 | $89.35 | $65.22 |
| Shareholders' equity | ||||
| Retained earnings | -$1118.48 | -$932.78 | -$612.82 | -$342.96 |
| Other shareholder equity | $0.05 | -$0.28 | -$0.15 | $0.01 |
| Total shareholder equity | $168.82 | $310.43 | $445.48 | $654.39 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $53.8 | $36.75 | $27.28 | $33.08 |
| Selling, general & administrative | $11.18 | $11.46 | $10.54 | $11.97 |
| Total operating expenses | $64.98 | $48.21 | $37.82 | $45.05 |
| Operating income | -$64.98 | -$48.21 | -$37.82 | -$45.05 |
| Income from continuing operations | ||||
| EBIT | -$64.93 | -$48.22 | -$37.82 | -$45.08 |
| Income tax expense | ||||
| Interest expense | -$2.38 | -$2.59 | -$2.7 | -$2.68 |
| Net income | ||||
| Net income | -$62.55 | -$45.63 | -$35.12 | -$42.4 |
| Income (for common shares) | -$62.55 | -$45.63 | -$35.12 | -$42.4 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $150.91 | $265.08 | $196.33 | $105.53 |
| Selling, general & administrative | $45.15 | $57.35 | $75.15 | $51.52 |
| Total operating expenses | $196.06 | $322.43 | $271.48 | $157.06 |
| Operating income | -$196.06 | -$322.43 | -$271.48 | -$157.06 |
| Income from continuing operations | ||||
| EBIT | -$196.05 | -$323.63 | -$270.24 | -$157.79 |
| Income tax expense | ||||
| Interest expense | -$10.35 | -$3.67 | -$0.38 | -$4.31 |
| Net income | ||||
| Net income | -$185.7 | -$319.95 | -$269.86 | -$153.48 |
| Income (for common shares) | -$185.7 | -$319.95 | -$269.86 | -$153.48 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$62.55 | -$45.63 | -$35.12 | -$42.4 |
| Operating activities | ||||
| Depreciation | $1.93 | $1.87 | $1.83 | $2 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $10.2 | $10.53 | $9.82 | $10.66 |
| Total cash flows from operations | -$24.27 | -$29.48 | -$32.59 | -$30.14 |
| Investing activities | ||||
| Capital expenditures | $0.03 | -$0.11 | -$0.25 | -$0.27 |
| Investments | $20.16 | $31.65 | $6.37 | $35.59 |
| Total cash flows from investing | $20.19 | $31.55 | $6.12 | $35.32 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.07 | $1.46 | ||
| Net borrowings | ||||
| Total cash flows from financing | $1.07 | $1.46 | ||
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$4.08 | $3.14 | -$26.47 | $6.64 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$185.7 | -$319.95 | -$269.86 | -$153.48 |
| Operating activities | ||||
| Depreciation | $7.63 | $9.97 | $4.88 | $2.34 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $41.22 | $43.16 | $50.84 | $33.45 |
| Total cash flows from operations | -$116.48 | -$279.97 | -$207.85 | -$113.92 |
| Investing activities | ||||
| Capital expenditures | -$0.59 | -$7.16 | -$33.22 | -$0.63 |
| Investments | $93.77 | $78.84 | $176.46 | $4.53 |
| Total cash flows from investing | $93.17 | $71.68 | $143.24 | $3.9 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $2.53 | $141.88 | $10.26 | $278.84 |
| Net borrowings | ||||
| Total cash flows from financing | $2.53 | $141.88 | $10.26 | $278.84 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$20.78 | -$66.41 | -$54.35 | $168.81 |
News
Fundamentals
| Market cap | $92.14M |
|---|---|
| Enterprise value | $63.91M |
| Shares outstanding | 87.75M |
| Revenue | $0.00 |
|---|---|
| EBITDA | -$188.42M |
| EBIT | -$196.05M |
| Net Income | -$185.70M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | -0.50 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | -0.34 |
| EV/EBIT | -0.33 |
| P/S ratio | N/A |
| P/B ratio | 0.55 |
| Book/Share | 1.92 |
| Cash/Share | 0.76 |
| EPS | -$2.12 |
|---|---|
| ROA | -62.07% |
| ROE | -80.28% |
| Debt/Equity | 0.44 |
|---|---|
| Net debt/EBITDA | -0.04 |
| Current ratio | 4.92 |
| Quick ratio | 4.92 |